PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President
29 Abril 2024 - 9:15AM
PetMed Express, Inc. ("PetMeds®" or the “Company”) (NASDAQ:
PETS), Your Trusted Pet Health Expert, today announced that the
Board of Directors has appointed veteran retail executive and
current PetMeds board member Sandra Campos as President and CEO,
effective immediately. Ms. Campos also remains on the Board
of Directors. Matt Hulett has stepped down as Chief Executive
Officer and President and as a Director of the Company and will
work with Ms. Campos to facilitate a smooth transition of
leadership responsibilities before departing the Company on May 10,
2024. He will remain an advisor to the Company through August
2024.
Campos, a globally recognized, seasoned
executive in consumer retail with over 25 years of leadership,
previously served as CEO of Diane von Furstenberg and President of
a portfolio of global brands including Juicy Couture, BCBG, Bebe
and Herve Leger. Ms. Campos’ focus on the ever-evolving
consumer landscape has transformed businesses for growth across
digital and physical retail through technology, innovative
marketing direct to the consumer, and supply chain diversification.
“Sandra is ideally suited to lead PetMeds’ next
chapter and the Board is confident in her ability to drive
sustainable profitable growth and shareholder value,” said Leslie
C. G. Campbell, Chairman of the Board. “She is a proven leader
and innovative marketer with a strategic, customer-centric mindset
and passion for the pet wellness industry. Her extensive experience
in building brands, evolving technology platforms, and driving
digital transformations, along with a strong track record of
operational excellence, will be instrumental in shaping our future
success.”
Speaking on the new role, Ms. Campos said, “I am
honored to be joining the PetMeds team as President and CEO and
bringing my deep-rooted experience and unwavering passion for the
industry to PetMeds at this pivotal time. Based on my background,
industry knowledge and understanding of the Company, I am confident
that this transition will unfold seamlessly, benefitting all
stakeholders of PetMeds.” Campos continued, “In partnership with
this dedicated Board, we will continue to focus on harnessing the
collective potential of both the PetMeds and PetCareRx teams to
propel growth, foster exceptional experiences for our customers and
employees and drive significant value for our shareholders. I look
forward to talking with analysts and shareholders after our
earnings call next month,” Campos concluded.
"It has been a privilege to lead this Company
and I am confident that Sandra's extensive experience and
leadership skills position her to guide PetMeds into a promising
future,” stated Mr. Hulett.
Ms. Campbell added, “The Board thanks Matt for
his contributions over the past two and a half years and wishes him
all the best in his future endeavors.”
About Sandra Campos
A globally recognized leader in consumer retail,
Sandra Campos is the former Chief Executive Officer of Diane von
Furstenberg and former President of a $1 billion portfolio of
brands including Juicy Couture, BCBG, Bebe and Herve Leger.
Before that time, Ms. Campos also held leadership roles with
apparel companies Polo Ralph Lauren and Nautica International. Ms.
Campos’ focus on the ever-evolving consumer landscape has
transformed businesses for growth across digital and physical
retail through technology, innovative marketing direct to the
consumer, and supply chain diversification. Balancing her career
between corporate roles and entrepreneurial ventures, she also
co-founded the first celebrity brand management company for Selena
Gomez, which included global licenses across fourteen categories.
Her breadth of knowledge across the retail ecosystem ranges from
software, product development, sourcing, and international
distributor/franchise partnerships, to digital marketing and
ecommerce. Ms. Campos serves as a Director of Big Lots Stores, and
is a regular CNBC contributor speaking on retail trends and
consumer news. She has been recognized in the top 100 Latina
Leaders and as a Top Woman in Retail.
ABOUT PETMEDS
Founded in 1996, PetMeds is Your Trusted Pet
Health Expert, delivering pet medications, food, health services
and other products direct to the consumer
at PetMeds.com and PetCareRX.com and through its
toll-free number (1-800-PetMeds). PetMeds aims to be the most
trusted pet health expert by providing incredible care and services
that are affordable to the broadest group of pet parents--because
every pet deserves to live a long, happy, healthy life. For more
information, please visit www.petmeds.com.
FORWARD-LOOKING STATEMENTS
This press release contains “forward-looking
statements” within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. All statements contained in this press release
that do not relate to matters of historical fact should be
considered forward-looking statements. Words such as “may,”
“could,” “expect,” “project,” “outlook,” “strategy,” “intend,”
“plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,”
“potential,” “strive,” “goal,” “continue,” “likely,” “will,”
“would” and other similar words and expressions are intended to
signify forward-looking statements. Such forward-looking statements
are necessarily based upon estimates and assumptions that, while
considered reasonable by the Company and its management, are
inherently uncertain and are subject to various risks and
uncertainties, including the Company’s ability to meet the
objectives in its business plan. The Company’s future results may
also be impacted by other risk factors listed from time to time in
the Company’s filings with the Securities and Exchange Commission
(“SEC”), including, but not limited to, the Company's Annual Report
on Form 10-K/A for the year ended March 31, 2023, as well as other
subsequent filings on Form 10-Q and periodic filings on Form 8-K.
You should not place undue reliance on these forward-looking
statements, which apply only as of the date of this press release
and should not be relied upon as representing the Company’s views
as of any subsequent date. The Company explicitly disclaims any
obligation to update any forward-looking statements, other than as
may be required by law. If the Company does update one or more
forward-looking statements, no inference should be made that the
Company will make additional updates with respect to those or other
forward-looking statements.
Investor Contact:MZ North
AmericaBrian M. Prenoveau, CFAinvestor@petmeds.com(561)
489-5315
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/895c6d2f-6e26-410e-b75e-e5da825c187c
PetMed Express (NASDAQ:PETS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
PetMed Express (NASDAQ:PETS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024